Clinical Outcomes of Treatment-Refractory Sclerodermatous Chronic Gvhd Patients Treated with IL-4/IL-13 Inhibition
2025; Elsevier BV; Volume: 31; Issue: 2 Linguagem: Inglês
10.1016/j.jtct.2025.01.434
ISSN2666-6367
AutoresJean Caputo, Benjamin H. Kaffenberger, Kristina D. Chadwick, Brittany Knauss, Karilyn Larkin, Sam Penza, Sarah Wall, Hannah Choe,
Tópico(s)Inflammatory Myopathies and Dermatomyositis
Referência(s)